Headlines

European Pre-Market Summary - 16th November 2026: European bourses set for a flat open

Newsquawk Staff ·

Stories

  • AstraZeneca (AZN LN): Co. reportedly cut c. 600 jobs across its US respiratory and immunology commercial teams as part of efforts to reallocate resources towards its drug development pipeline, according to Bloomberg sources.
  • Barclays (BARC LN): Co. is reportedly preparing to cut c. 200 investment banking jobs, primarily in New York and London, as early as Tuesday, according to Bloomberg sources.
  • Stellantis (STLAM IM/STLAP FP): Canadian Industry Minister Joly says the Co. owes the government hundreds of millions of dollars after failing to restart production at a plant near Toronto.

Healthcare Updates

  • Novartis (NOVN SW): Co. announces that it received a positive CHMP opinion of Cosentyx for adolescents aged 12 years and older.
  • Roche (ROP SW): Co. announces that the US FDA has approved Gazyva/Gazyvaro for the treatment of adult patients with primary membranous nephropathy at risk of disease progression.
  • Novo Nordisk (NOVOB DC): Co. reported positive Phase 3 Redefine 9 results for lower-dose CagriSema in overweight or obese adults. At week 68, doses of 1.7mg/1.7mg and 1.0mg/1.0mg achieved estimated average weight loss of 20.7% and 21.0%, respectively, versus 2.0% with placebo.

Broker Moves

  • Generali (G IM) downgraded to Reduce from Add at AlphaValue
  • Geberit (GEBN SW) downgraded to Hold from Buy at Jefferies
  • Holcim (HOLN SW) upgraded to Buy from Hold at Jefferies

Related headlines